GRM1

Private Equity, VC & Investor

Greenoaks vs M13

Structured technology and market comparison · 2026

Direct Feature Comparison

Greenoaks · vs · M13
Market Cluster / Sector
GreenoaksPrivate Equity, VC & Investor
M13Private Equity, VC & Investor
Platform Focus
Greenoaks

Concentrated long-term venture investor in technology businesses.

M13

Early-stage venture capital firm backing market-creating founders.

Company Size
Greenoaks10–49 employees
M13201–500 employees
Headquarters
GreenoaksUS
M13US
Year Founded
Greenoaks2012
M132016

Analyze all overlapping signals and tech stacks for Greenoaks and M13

Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.

Compare free in ExplorerFree · No credit card · 1-click via Google/LinkedIn

Comparison Analysis

What is the main difference between Greenoaks and M13?

When comparing Greenoaks and M13, both platforms operate within the Private Equity, VC & Investor ecosystem. Greenoaks is positioned as Concentrated long-term venture investor in technology businesses, whereas M13 focuses on Early-stage venture capital firm backing market-creating founders. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.

What are the top alternatives to Greenoaks and M13?

When evaluating Greenoaks and M13, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.

How do the corporate scale, structure, and headquarters of Greenoaks and M13 compare?

Greenoaks is headquartered in US (founded in 2012) with 10–49 employees. M13 is based in US (founded in 2016) with 201–500 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.

Market Signals

Recent Market Signals & Activity: Greenoaks vs M13

Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.

GR

Greenoaks

Recent Signals

  • ·CNBC TechnologyPrivacy

    Coupang dispute raises U.S. tariff pressure on South Korea

    A Republican-led House Judiciary report alleges the South Korean government mounted a targeted campaign against U.S.-headquartered Coupang after a 2025 data breach, prompting calls from some U.S. lawmakers and investors for formal trade investigations and potential tariffs. South Korea disputes the report, defends its actions and the scale of the breach, and says it has engaged with U.S. officials. Investors including Greenoaks and Altimeter urged the U.S. Trade Representative to open a Section 301 probe. The dispute comes amid broader U.S.-South Korea tensions over trade commitments, security cooperation and earlier tariff actions.

    • House Judiciary Committee Republicans released a report alleging the South Korean government waged a targeted offensive against Coupang following a data breach.
    • South Korea levied a 625 billion won (about $409 million) data-privacy fine on Coupang; Seoul says the breach affected 37.55 million people.
    • Investors Greenoaks Capital Partners and Altimeter Capital petitioned the U.S. Trade Representative in January to open a Section 301 investigation into South Korea over its treatment of Coupang.
  • ·AINews swyxBehavioral simulation and synthetic populations for decision-making

    Simile AI: Behavioral Simulation and Scaling Laws

    This podcast episode with Simile co-founder and CEO Joon Sung Park explores the company’s work building behavioral foundation models and synthetic populations for simulation. The discussion covers Simile’s methodology (interviews, transaction/observational data, randomized controlled trials, and post-training on causal mechanisms), validated research (a 1,000-person study where digital twins reproduced human behavior ~85% as accurately as the original humans), enterprise use cases (tens of millions of simulations for Fortune 100 clients like CVS), and the broader ambition to scale multi-agent simulations toward society-scale models. The episode also mentions Simile’s recent Series B at a $2B valuation and funding/backers reported in coverage.

    • Simile AI is reported to have a Series B at a $2 billion valuation.
    • Simile runs tens of millions of simulations for enterprise customers, including Fortune 100 clients like CVS.
    • In a representatively sampled 1,000-person study, Simile’s digital twins reproduced human behavior and attitudes about 85% as accurately as the original humans reproduced their own responses.
  • ·techcrunchFundraising

    Simile Raises $200M Series B at $2B Valuation

    Simile, a startup that builds synthetic/simulated users for marketing and product research, raised $200 million in a Series B at a $2 billion valuation. The round, announced July 30, 2026, was led by Greenoaks with participation from Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures. The raise comes five months after Simile's $100 million Series A led by Index. Simile was founded by Joon Sung Park and counts CVS among its customers. The company positions its technology as a way to simulate user behavior for research and product testing, attracting growing VC interest in the synthetic-user market.

    • Simile closed a $200 million Series B at a $2 billion valuation (announced 2026-07-30).
    • The Series B was led by Greenoaks with participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition and CVS Health Ventures.
    • The raise comes five months after Simile announced a $100 million Series A led by Index Ventures.
M1

M13

Recent Signals

  • ·M13

    What Is Agentic Identity? Meet Baselayer, the Identity Infrastructure for AI Agents

    M13 announces fundraising for Baselayer, an identity infrastructure for AI agents, with a dedicated article published on September 22, 2026.

  • ·NewcomerAgentic Commerce

    Investors Are Betting on AI Agents That Shop for You

    Venture capitalists are increasingly funding startups building AI agents that can shop on behalf of consumers and handle payments. The article maps the emerging market for "agentic commerce," covering personal assistants like Instinct and Town, shopping search tools like Daydream, payment infrastructure startups like Catena Labs and Basis Theory, and marketing tech such as Profound. Major platforms are also moving: OpenAI and Stripe launched the Agentic Commerce Protocol, Google operates the Agent Payments Protocol, and Visa and Mastercard introduced Trusted Agent Protocol and Agent Pay. However, the space faces trust and fraud challenges, illustrated by Phia's cookie-stuffing scandal and an Instinct agent error that cost a user around $300. Investor interest remains strong, with millions raised across the sector, even as enterprise adoption lags due to compliance and security concerns.

    • Adobe Analytics reported that 41% of respondents used AI for online shopping in June 2026.
    • OpenAI and Stripe launched the Agentic Commerce Protocol (ACP), while Google operates the Agent Payments Protocol.
    • Profound raised $96 million in Series C funding led by Lightspeed Venture Partners.

Compare their exact ecosystem overlaps.

Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Greenoaks and M13 share across the market ecosystem.